Temporal Dynamics of the Circulating Cytokinome in Severe Alcohol-Associated Hepatitis: A Longitudinal Clinical Analysis

MedXY Editorial Team•Mar 28, 2026•Clinical Updates

Severe alcohol-associated hepatitis (AH) is characterized by a massive systemic inflammatory response that involves distinct longitudinal kinetics for over 40 distinct immune biomarkers.
The interleukin-1 (IL-1) pathway shows divergent responses to treatment: anakinra (IL-1Ra) induces early elevation of IL-1 receptor antagonists, while corticosteroids are associated with delayed increases in IL-1β.
Survivors exhibit a trend toward biomarker normalization, yet systemic immune dysregulation persists in most patients up to 180 days post-diagnosis.
Mortality prediction in severe AH is treatment-sensitive, with IL-13 levels and changes in Sonic hedgehog signaling serving as significant prognostic indicators.

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Severe alcohol-associated hepatitis (AH) is characterized by a massive systemic inflammatory response that involves distinct longitudinal kinetics for over 40 distinct immune biomarkers.
The interleukin-1 (IL-1) pathway shows divergent responses to treatment: anakinra (IL-1Ra) induces early elevation of IL-1 receptor antagonists, while corticosteroids are associated with delayed increases in IL-1β.
Survivors exhibit a trend toward biomarker normalization, yet systemic immune dysregulation persists in most patients up to 180 days post-diagnosis.
Mortality prediction in severe AH is treatment-sensitive, with IL-13 levels and changes in Sonic hedgehog signaling serving as significant prognostic indicators.